Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kui Ming Chan

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Molecular Neurobiology|July 28, 2018
TSPYL2 Regulates the Expression of EZH2 Target Genes in NeuronsHang Liu, Lei Peng, Joan So, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2010
FGF receptor-4 (FGFR4) polymorphism acts as an activity switch of a membrane type 1 matrix metalloproteinase-FGFR4 complexNami Sugiyama, Markku Varjosalo, Pipsa Meller, et al.
Nature Communications|August 17, 2023
ATF3 induction prevents precocious activation of skeletal muscle stem cell by regulating H2B expressionSuyang Zhang, Feng Yang, Yile Huang, et al.
The EMBO Journal|May 17, 2011
MT1-MMP cleaves Dll1 to negatively regulate Notch signalling to maintain normal B-cell developmentGuoxiang Jin, Fengju Zhang, Kui Ming Chan, et al.
Epigenetics & Chromatin|November 10, 2024
FOSL1 is a key regulator of a super-enhancer driving TCOF1 expression in triple-negative breast cancerQingling He, Jianyang Hu, Hao Huang, et al.
Genes & Development|April 23, 2013
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expressionKui-Ming Chan, Dong Fang, Haiyun Gan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 8, 2024
TSPYL1 as a Critical Regulator of TGFβ Signaling through Repression of TGFBR1 and TSPYL2Huiqi Tan, Mia Xinfang Miao, Rylee Xu Luo, et al.
Nature Methods|June 24, 2020
CRISPR-assisted detection of RNA-protein interactions in living cellsWenkai Yi, Jingyu Li, Xiaoxuan Zhu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2026
A pharmacovigilance data-driven approach to reveal high fatal adverse events following checkpoint immunotherapyZhen Sun, Xuan Deng, Jianglong Guo, et al.
Cell Reports|November 24, 2025
Dual inhibition of FACT and RRM2 suppresses the progression of pancreatic ductal adenocarcinoma driven by the oncohistone H2BG53DTiantian Qin, Yi Ching Esther Wan, Shiman Hu, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Molecular Neurobiology|July 28, 2018
TSPYL2 Regulates the Expression of EZH2 Target Genes in NeuronsHang Liu, Lei Peng, Joan So, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2010
FGF receptor-4 (FGFR4) polymorphism acts as an activity switch of a membrane type 1 matrix metalloproteinase-FGFR4 complexNami Sugiyama, Markku Varjosalo, Pipsa Meller, et al.
Nature Communications|August 17, 2023
ATF3 induction prevents precocious activation of skeletal muscle stem cell by regulating H2B expressionSuyang Zhang, Feng Yang, Yile Huang, et al.
The EMBO Journal|May 17, 2011
MT1-MMP cleaves Dll1 to negatively regulate Notch signalling to maintain normal B-cell developmentGuoxiang Jin, Fengju Zhang, Kui Ming Chan, et al.
Epigenetics & Chromatin|November 10, 2024
FOSL1 is a key regulator of a super-enhancer driving TCOF1 expression in triple-negative breast cancerQingling He, Jianyang Hu, Hao Huang, et al.
Genes & Development|April 23, 2013
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expressionKui-Ming Chan, Dong Fang, Haiyun Gan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 8, 2024
TSPYL1 as a Critical Regulator of TGFβ Signaling through Repression of TGFBR1 and TSPYL2Huiqi Tan, Mia Xinfang Miao, Rylee Xu Luo, et al.
Nature Methods|June 24, 2020
CRISPR-assisted detection of RNA-protein interactions in living cellsWenkai Yi, Jingyu Li, Xiaoxuan Zhu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2026
A pharmacovigilance data-driven approach to reveal high fatal adverse events following checkpoint immunotherapyZhen Sun, Xuan Deng, Jianglong Guo, et al.
Cell Reports|November 24, 2025
Dual inhibition of FACT and RRM2 suppresses the progression of pancreatic ductal adenocarcinoma driven by the oncohistone H2BG53DTiantian Qin, Yi Ching Esther Wan, Shiman Hu, et al.
Pageof 5